BAC
Bank of America Corporation
BAC's fundamentals are strong: its operating margin rose 5 points to 35% and revenue grew 15%. At 12x earnings, it's trading in line with its usual 13x. Analysts expect earnings growth.
CLST
Catalyst Bancorp, Inc.
There isn't enough reported data to score CLST yet.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
CLST Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| N/A | |
| N/A |
CLST's profitability is currently healthy, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like CLST.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC's PE is in its fair range at 12x. If earnings grow as analysts expect, today's price would be 10x next year's earnings, in its cheap range.
CLST PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 25x | $13.68 | -22% |
| Current | 25x | $17.57 | — |
| Fair | 31x | $16.82 | -4.3% |
| Expensive | 126x | $69.15 | +294% |
Historical ranges are pointers, not guarantees.
CLST has the edge over BAC in the historical PE scenario, which offers more potential upside but is not a forecast.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
CLST Forward outlook
There aren't enough analyst estimates for CLST to show an outlook.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC's earnings per share have climbed steadily: $4.19 over the past year, up 14% from the year before, and higher year over year for eight quarters in a row.
CLST Earnings Per Share
CLST and BAC do not have enough comparable growth data to identify a winner.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the edge over CLST on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC has the edge over CLST on profitability, with a higher operating margin.
CLST Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $3M | +5% |
| Q1 2026 | $2.9M | -0.7% |
| Q4 2025 | $2.7M | -5.6% |
| Q3 2025 | $2.8M | -12% |
| Q2 2025 | $2.8M | -0.1% |
| Q4 2024 | $2.8M | +6.7% |
| Q3 2024 | $3.2M | +38% |
| Q2 2024 | $2.8M | +27% |
CLST's revenue fell from its 2021 peak and has held roughly level since: $3M last quarter, up 5% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 23% | +0.3 points |
| Q1 2026 | 24% | -1.1 points |
| Q4 2025 | 21% | -6.7 points |
| Q3 2025 | 22% | +4.1 points |
| Q2 2025 | 23% | -0.4 points |
| Q1 2025 | 25% | N/A |
| Q4 2024 | 27% | +13 points |
| Q3 2024 | 18% | +9 points |
CLST's operating margin was 23% last quarter, about level with the same quarter a year ago.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC has the edge over CLST on cash flow, with more consistent year-over-year improvement.
CLST Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $958K | -14% |
| Q1 2026 | $657K | +82% |
| Q4 2025 | $794K | +37% |
| Q3 2025 | $827K | +7.3% |
| Q2 2025 | $1.1M | -4.3% |
| Q4 2024 | $581K | -37% |
| Q3 2024 | $771K | +97% |
| Q4 2023 | $916K | +142% |
CLST's free cash flow was $3M over the past year, up 14% from the year before. Free cash flow isn't a meaningful measure for financial services companies like CLST.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over CLST on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
CLST Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +6K shares |
| 1 year | -0.6% | -22K shares |
| 3 years | -21% | -969K shares |
CLST has 4M diluted shares, down 0.6% from a year ago, with $2M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q2 2026 | $393,000 |
| Q1 2026 | $260,000 |
| Q4 2025 | $807,000 |
| Q3 2025 | $171,000 |
| Q2 2025 | $742,000 |
| Q1 2025 | $866,000 |
| Q4 2024 | $1.4M |
| Q3 2024 | $933,000 |
CLST spent $2M buying back its own shares over the past year, down 59% from the year before.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
CLST Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -9.3x | Net Cash |
| Q1 2026 | -10.0x | Net Cash |
| Q4 2025 | -3.6x | Net Cash |
| Q3 2025 | -7.2x | Net Cash |
| Q2 2025 | -9.8x | Net Cash |
| Q1 2025 | -9.9x | Net Cash |
| Q4 2023 | 0.3x | Very low |
| Q3 2023 | -4.4x | Net Cash |
CLST has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
CLST Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.8 | Neutral |
| Stochastic | 27.9 | Neutral |
CLST's weekly RSI is 58 (neutral) and its Stochastic is 28 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC has the edge over CLST on valuation relative to its sector.
CLST PE vs Financial Services Sector
| Metric | CLST | Sector median | Relative |
|---|---|---|---|
| PE | 25x | 13x | 96% above |
| PE % | 21 | 65 | 44 pts below |
CLST is trading at 25x earnings, a 96% premium to the Financial Services sector's median of 13x, though its earnings don't support one.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
CLST Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $17.2 | 2.4% above |
| 20 week MA | $17.2 | 2% above |
| 50 week MA | $16.5 | 6.6% above |
| 100 week MA | $14.4 | 22% above |
| 200 week MA | $13.0 | 35% above |
CLST has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
CLST Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $13.9 | $13.9 | +0.3% |
| 2022 | $13.9 | $12.8 | -8.1% |
| 2023 | $12.8 | $10.8 | -15% |
| 2024 | $10.8 | $11.7 | +7.9% |
| 2025 | $11.7 | $15.5 | +33% |
| 2026 YTD | $15.5 | $17.6 | +13% |
CLST has the edge over BAC on returns for 2026, with the stronger performance.